AV
Avanos Medical, Inc.
AVNS · NYSE
$24.99 +0.04% (+$0.01)
Market Cap $1.17B
P/E Ratio -
Div. Yield -
ROE 8.55%
Bulios Fair Price
$20.38
18.4% downside
Current Price
$24.99
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AVNS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
68 /100
Cheap P/B 1.50x
P/FCF 27.16x
P/S 1.67x
Growth
12 /100
Declining FCF growth 15.57%
Book val. growth 15.53%
Rev. growth 0.83%
Profitability
34 /100
Moderate Net margin 9.68%
Op. margin 8.78%
FCF margin 6.15%
Quality
8 /100
Poor ROE 8.55%
ROA 6.32%
Asset turnover 0.65x
Debt
69 /100
Low Current ratio 2.15x
Int. coverage -15.55x
Debt/Equity 0.17x
Stability
38 /100
Moderate Rev. volatility 2.10%
EPS volatility 312.13%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AVNS
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
David C. Pacitti
Employees
2,287
Headquarters
Alpharetta